Stock of the Day for December 10, 2024

Thermo Fisher Scientific Stock Report

Thermo Fisher Scientific
TMO 90-day performance NYSE:TMO Thermo Fisher Scientific
Current Price
$479.48
-11.93 (-2.43%)
(As of 09/12/2025 03:59 PM ET)
30 Day Performance
-2.14%
  
  
90 Day Performance
22.89%
  
 
1 Year Performance
-21.55%
  
  
Market Capitalization
$181.06B
P/E Ratio
27.73
Dividend Yield
0.36%

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, reagents and consumables, software, and services that advance research, diagnostics, and pharmaceutical manufacturing. The company’s main business activities are organized into four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its product offerings include benchtop and high-throughput instruments, chromatography and mass spectrometry systems, cell culture media, antibodies and assays, clinical diagnostic kits, and custom biopharma development and manufacturing services.

Formed in 2006 through the merger of Thermo Electron and Fisher Scientific, Thermo Fisher has built a global reputation by combining deep domain expertise with broad product portfolios. Over the years, it has expanded both organically and through targeted acquisitions to address emerging challenges in genomics, proteomics, clinical diagnostics, personalized medicine, and environmental testing. The company continues to invest in research and development, aiming to deliver novel solutions that accelerate scientific discovery and improve patient outcomes.

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific operates in more than 50 countries and serves customers across North America, Europe, Asia Pacific, Latin America, and the Middle East. Its geographic reach supports a diverse clientele, including academic institutions, government agencies, hospitals, pharmaceutical and biotechnology companies, and industrial laboratories. The company’s logistics network and field service teams are designed to ensure reliable product delivery, technical support, and application training on a global scale.

Under the leadership of President and Chief Executive Officer Marc N. Casper, Thermo Fisher Scientific maintains a focus on innovation, operational excellence, and sustainable growth. The company emphasizes collaboration with its customers and partners to co-develop solutions that address complex scientific and healthcare challenges. By aligning strategic investments with evolving market needs, Thermo Fisher seeks to reinforce its position as a trusted partner in the global life sciences and diagnostics ecosystem.

TMO Company Calendar

JUN. 13, 2025
Ex-Dividend for 7/15 Dividend
JUL. 15, 2025
Dividend Payable
JUL. 23, 2025
Last Earnings
SEP. 15, 2025
Today
SEP. 15, 2025
Ex-Dividend for 10/15 Dividend
OCT. 15, 2025
Dividend Payable
OCT. 22, 2025
Next Earnings (Estimated)
DEC. 31, 2025
Fiscal Year End

Recent Thermo Fisher Scientific News

Thermo Fisher Scientific Inc. $TMO Shares Acquired by Swedbank AB
Guinness Asset Management LTD Raises Stake in Thermo Fisher Scientific Inc. $TMO
Barclays Upgrades Thermo Fisher Scientific (NYSE:TMO) to "Overweight"
This report was written by MarketBeat.com on September 15, 2025. This report first appeared on MarketBeat.com.